{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:06:10Z","timestamp":1759410370152},"reference-count":41,"publisher":"Elsevier BV","issue":"23-24","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.vaccine.2004.02.007","type":"journal-article","created":{"date-parts":[[2004,3,5]],"date-time":"2004-03-05T12:28:03Z","timestamp":1078489683000},"page":"3053-3060","source":"Crossref","is-referenced-by-count":31,"title":["Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen"],"prefix":"10.1016","volume":"22","author":[{"given":"Poonam","family":"Tewary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bindu","family":"Sukumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailendra","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rentala","family":"Madhubala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.02.007_BIB1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0163-4453(94)91059-6","article-title":"Visceral Leishmanisis: more prevalent and more problematic","volume":"29","author":"Baily","year":"1994","journal-title":"J. Infect."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.02.007_BIB3","unstructured":"World Health Report. Thirteenth programme report. Special programme for research and training in tropical diseases. Leishmaniasis. Geneva: World Health Organizations Publications; 1997."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB4","unstructured":"World Health Organization. Advances in battle against Leishmaniasis. TDR News 1998;57:2."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB5","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1099\/13500872-141-7-1585","article-title":"Recombinant BCG expressing the leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB\/c mice","volume":"141","author":"Abdelhak","year":"1995","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2004.02.007_BIB6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0065-308X(08)60152-9","article-title":"DNA vaccines: technology and applications as anti-parasite and anti-microbial agents","volume":"42","author":"Alarcon","year":"1999","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB7","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0020-7519(97)00112-4","article-title":"Designer vaccines for parasitic diseases","volume":"27","author":"Cox","year":"1997","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0264-410X(00)00207-3","article-title":"Immunization with recombinant LD1 antigens protects against experimental leishmaniasis","volume":"19","author":"Dole","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.02.007_BIB9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-3024.2000.00278.x","article-title":"Immunotherapy with live BCG plus heat killed leishmania induces a T helper-1 like response in American cutaneous leishmaniasis patients","volume":"22","author":"Cabrera","year":"2000","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0169-4758(97)01060-0","article-title":"Leishmania vaccines: old and new","volume":"13","author":"Handman","year":"1997","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.vaccine.2004.02.007_BIB11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","article-title":"Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to the mice infected with Leishmania major","volume":"186","author":"Gurunathan","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB12","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.4049\/jimmunol.160.8.3949","article-title":"Induction of a Th1 response and simultaneous lack of activation of a Th2 response is required for generation of immunity to leishmaniasis","volume":"160","author":"Sjolanader","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB13","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1 and Th2 derived cytokines does not determine the genetically controlled or vaccine induced rate of cure in murine leishmaniasis","volume":"146","author":"Kaye","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB14","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI116372","article-title":"In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma","volume":"91","author":"Karp","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/IAI.61.3.1069-1073.1993","article-title":"Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis","volume":"61","author":"Kemp","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/cimm.1996.0009","article-title":"Bacterial DNA induces murine interferon gamma production by stimulation of IL-12 and tumor necrosis factor alpha","volume":"167","author":"Halpern","year":"1996","journal-title":"Cell Immunol."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB17","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1073\/pnas.93.7.2879","article-title":"CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12, and IFN-gamma","volume":"93","author":"Klinman","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2004.02.007_BIB19","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.4049\/jimmunol.156.12.4570","article-title":"Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides","volume":"156","author":"Cowdery","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB20","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.4049\/jimmunol.147.6.1759","article-title":"Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA","volume":"147","author":"Messina","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB21","first-page":"955","article-title":"Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity","volume":"72","author":"Tokunaga","year":"1984","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB22","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1073\/pnas.94.20.10833","article-title":"Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization","volume":"94","author":"Weiner","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB23","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB24","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","article-title":"CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen","volume":"160","author":"Davis","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm0897-849","article-title":"Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants","volume":"3","author":"Roman","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB26","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20020147","article-title":"Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection","volume":"195","author":"Rhee","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB27","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.160.8.3627","article-title":"CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis","volume":"160","author":"Zimmermann","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/expr.1999.4453","article-title":"Leishmania donovani: characterization and expression of ORFF, a gene amplified from the LD1 locus","volume":"93","author":"Ghosh","year":"1999","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0378-1119(94)90688-2","article-title":"A frequently amplified region in Leishmania contains a gene that is conserved in prokaryotes and eukaryotes","volume":"148","author":"Myler","year":"1994","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2004.02.007_BIB30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0166-6851(92)90125-4","article-title":"A multicopy, extrachromosomal DNA in Leishmania infantum contains two inverted repeats of the 27.5kb LD1 sequence and encodes numerous transcripts","volume":"55","author":"Tripp","year":"1992","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB31","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0264-410X(02)00352-3","article-title":"Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani","volume":"21","author":"Sukumaran","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.02.007_BIB32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrite, nitrate and [15N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB33","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1073\/pnas.96.12.6970","article-title":"Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12 and IFN-gamma dependent mechanisms","volume":"96","author":"Walker","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0264-410X(98)00151-0","article-title":"CpG motifs as immune adjuvants","volume":"17","author":"Klinman","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.02.007_BIB35","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/IAI.67.8.3719-3726.1999","article-title":"Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major","volume":"67","author":"Stacey","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB36","unstructured":"Fisher RA, Yates F. Student\u2019s t-test of significance. In: statistical tables for agricultural and other research workers. Edinburg: Oliver and Boyd; 1957. p. 1024\u20139."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1084\/jem.20030645","article-title":"Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice","volume":"198","author":"Shah","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB38","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1128\/IAI.71.9.5121-5129.2003","article-title":"Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous leishmaniasis but maintains its potency and durability","volume":"71","author":"Mendez","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB39","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.4049\/jimmunol.170.9.4717","article-title":"CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection","volume":"170","author":"Verthelyi","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB40","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application and optimization","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.vaccine.2004.02.007_BIB41","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/eji.200323671","article-title":"Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T-cell activation","volume":"33","author":"Datta","year":"2003","journal-title":"Eur. J. Immunol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0400146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0400146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T02:10:47Z","timestamp":1682647847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0400146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":41,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0264410X0400146X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.02.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}